{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T20:58:28Z","timestamp":1785445108318,"version":"3.56.0"},"reference-count":114,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Soc Psychiatry Psychiatr Epidemiol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00127-026-03062-y","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T08:17:39Z","timestamp":1771921059000},"page":"1305-1316","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Psychotropic medication non-adherence and its determinants among adult psychiatric patients in Ethiopia"],"prefix":"10.1007","volume":"61","author":[{"given":"Mulu","family":"Getnet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanuel","family":"Gashaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Endalamaw","family":"Salelew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biruk","family":"Fanta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mulualem","family":"Kelebie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,24]]},"reference":[{"issue":"2","key":"3062_CR1","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1177\/1529100617727266","volume":"18","author":"LA Clark","year":"2017","unstructured":"Clark LA, Cuthbert B, Lewis-Fern\u00e1ndez R, Narrow WE, Reed GM (2017) Three approaches to Understanding and classifying mental disorder: ICD-11, DSM-5, and the National Institute of mental health\u2019s research domain criteria (RDoC). Psychol Sci Public Interest 18(2):72\u2013145","journal-title":"Psychol Sci Public Interest"},{"issue":"9926","key":"3062_CR2","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1016\/S0140-6736(13)62382-X","volume":"383","author":"KS Jacob","year":"2014","unstructured":"Jacob KS, Patel V (2014) Classification of mental disorders: a global mental health perspective. Lancet 383(9926):1433\u20131435","journal-title":"Lancet"},{"issue":"10157","key":"3062_CR3","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1016\/S0140-6736(18)31612-X","volume":"392","author":"V Patel","year":"2018","unstructured":"Patel V, Saxena S, Lund C, Thornicroft G, Baingana F, Bolton P et al (2018) The Lancet commission on global mental health and sustainable development. Lancet 392(10157):1553\u20131598","journal-title":"Lancet"},{"issue":"10","key":"3062_CR4","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1176\/appi.ajp.157.10.1679","volume":"157","author":"JG Johnson","year":"2000","unstructured":"Johnson JG, Cohen P, Brook JS (2000) Associations between bipolar disorder and other psychiatric disorders during adolescence and early adulthood: a community-based longitudinal investigation. Am J Psychiatry 157(10):1679\u20131681","journal-title":"Am J Psychiatry"},{"issue":"9926","key":"3062_CR5","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1016\/S0140-6736(13)62633-1","volume":"383","author":"O Eyre","year":"2014","unstructured":"Eyre O, Thapar A (2014) Common adolescent mental disorders: transition to adulthood. Lancet 383(9926):1366\u20131368","journal-title":"Lancet"},{"issue":"suppl 3","key":"3062_CR6","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4088\/JCP.7075su1c.04","volume":"70","author":"A Fagiolini","year":"2009","unstructured":"Fagiolini A, Goracci A (2009) The effects of undertreated chronic medical illnesses in patients with severe mental disorders. J Clin Psychiatry 70(suppl 3):22\u201329","journal-title":"J Clin Psychiatry"},{"key":"3062_CR7","doi-asserted-by":"crossref","unstructured":"Carta MG, Patten S, Nardi AE, Bhugra D (2017) Mental health and chronic diseases: a challenge to be faced from a new perspective. Taylor & Francis, pp 373\u2013376","DOI":"10.1080\/09540261.2017.1364885"},{"issue":"5","key":"3062_CR8","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1097\/01.pra.0000388626.98662.a0","volume":"16","author":"DI Velligan","year":"2010","unstructured":"Velligan DI, Weiden PJ, Sajatovic M, Scott J, Carpenter D, Ross R et al (2010) Strategies for addressing adherence problems in patients with serious and persistent mental illness: recommendations from the expert consensus guidelines. J Psychiatric Practice\u00ae 16(5):306\u2013324","journal-title":"J Psychiatric Practice\u00ae"},{"issue":"S17","key":"3062_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1017\/S1092852900026304","volume":"12","author":"JM Kane","year":"2007","unstructured":"Kane JM (2007) Treatment adherence and long-term outcomes. CNS Spectr 12(S17):21\u201326","journal-title":"CNS Spectr"},{"issue":"1","key":"3062_CR10","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1186\/s12889-025-22095-7","volume":"25","author":"M Kelebie","year":"2025","unstructured":"Kelebie M, Fentahun S, Tadesse G, Nakie G, Medfu G, Fasil B et al (2025) Predictors of long-term outcome of patients with schizophrenia in africa: systematic review and meta-analysis. BMC Public Health 25(1):814","journal-title":"BMC Public Health"},{"issue":"2","key":"3062_CR11","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S2215-0366(21)00395-3","volume":"9","author":"GMD Collaborators","year":"2022","unstructured":"Collaborators GMD (2022) Global, regional, and National burden of 12 mental disorders in 204 countries and territories, 1990\u20132019: a systematic analysis for the global burden of disease study 2019. Lancet Psychiatry 9(2):137\u2013150","journal-title":"Lancet Psychiatry"},{"key":"3062_CR12","doi-asserted-by":"crossref","unstructured":"Kumar PM, Kumar VU, Meenakshi S, Bahekar TN, Narapaka PK, Dhingra S et al (2024) Epidemiology and risk factors of mental disorders. A Review on Diverse Neurological Disorders: Elsevier; pp. 3\u201312","DOI":"10.1016\/B978-0-323-95735-9.00003-6"},{"issue":"1","key":"3062_CR13","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1186\/s12888-025-06932-y","volume":"25","author":"Y Fan","year":"2025","unstructured":"Fan Y, Fan A, Yang Z, Fan D (2025) Global burden of mental disorders in 204 countries and territories, 1990\u20132021: results from the global burden of disease study 2021. BMC Psychiatry 25(1):486","journal-title":"BMC Psychiatry"},{"issue":"1","key":"3062_CR14","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13643-018-0676-y","volume":"7","author":"A Semahegn","year":"2018","unstructured":"Semahegn A, Torpey K, Manu A, Assefa N, Tesfaye G, Ankomah A (2018) Psychotropic medication non-adherence and associated factors among adult patients with major psychiatric disorders: a protocol for a systematic review. Syst Reviews 7(1):10","journal-title":"Syst Reviews"},{"issue":"3","key":"3062_CR15","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/wps.20060","volume":"12","author":"JM Kane","year":"2013","unstructured":"Kane JM, Kishimoto T, Correll CU (2013) Non-adherence to medication in patients with psychotic disorders: epidemiology, contributing factors and management strategies. World Psychiatry 12(3):216\u2013226","journal-title":"World Psychiatry"},{"issue":"10","key":"3062_CR16","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.4088\/JCP.v67n1008","volume":"67","author":"M Valenstein","year":"2006","unstructured":"Valenstein M, Ganoczy D, McCarthy JF, Myra Kim H, Lee TA, Blow FC (2006) Antipsychotic adherence over time among patients receiving treatment for schizophrenia: a retrospective review. J Clin Psychiatry 67(10):1542\u20131550","journal-title":"J Clin Psychiatry"},{"issue":"11","key":"3062_CR17","doi-asserted-by":"publisher","first-page":"e0302350","DOI":"10.1371\/journal.pone.0302350","volume":"19","author":"E Niyokwizera","year":"2024","unstructured":"Niyokwizera E, Nitunga D, Muhumuza J, Niyubahwe RMI, Abamara NC, Kirabira J (2024) Personality traits and other factors associated with psychotropic medication non-adherence at two hospitals in Uganda. A cross-sectional study. PLoS ONE 19(11):e0302350","journal-title":"PLoS ONE"},{"key":"3062_CR18","doi-asserted-by":"crossref","unstructured":"Chukwujekwu C (2017) Prevalence of medication non-adherence among psychiatric patients in a tertiary hospital in Nigeria. J Biosci Med","DOI":"10.4236\/jbm.2017.54001"},{"issue":"1","key":"3062_CR19","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1192\/bjo.2020.141","volume":"7","author":"M Sajatovic","year":"2021","unstructured":"Sajatovic M, Mbwambo J, Lema I, Blixen C, Aebi ME, Wilson B et al (2021) Correlates of poor medication adherence in chronic psychotic disorders. BJPsych Open 7(1):e23","journal-title":"BJPsych Open"},{"issue":"1","key":"3062_CR20","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1186\/s12889-025-22408-w","volume":"25","author":"G Tadesse","year":"2025","unstructured":"Tadesse G, Geremew GW, Alemayehu TT, Getachew D, Demelash D, Fentahun S (2025) Psychotropic medication non-adherence and its determinants among people living with mental illnesses in ethiopia: systematic review and meta-analysis study. BMC Public Health 25(1):1333","journal-title":"BMC Public Health"},{"issue":"10","key":"3062_CR21","doi-asserted-by":"publisher","first-page":"e0258729","DOI":"10.1371\/journal.pone.0258729","volume":"16","author":"M Koschorke","year":"2021","unstructured":"Koschorke M, Oexle N, Ouali U, Cherian AV, Deepika V, Mendon GB et al (2021) Perspectives of healthcare providers, service users, and family members about mental illness stigma in primary care settings: A multi-site qualitative study of seven countries in Africa, Asia, and Europe. PLoS ONE 16(10):e0258729","journal-title":"PLoS ONE"},{"key":"3062_CR22","unstructured":"Lou H (2023) Factors influencing client experience with a community-based intervention for adult depression in Vietnam"},{"issue":"1","key":"3062_CR23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13033-017-0126-6","volume":"11","author":"MK Iseselo","year":"2017","unstructured":"Iseselo MK, Ambikile JS (2017) Medication challenges for patients with severe mental illness: experience and views of patients, caregivers and mental health care workers in Dar Es Salaam, Tanzania. Int J Mental Health Syst 11(1):17","journal-title":"Int J Mental Health Syst"},{"issue":"1","key":"3062_CR24","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13033-016-0061-y","volume":"10","author":"S Oppong","year":"2016","unstructured":"Oppong S, Kretchy IA, Imbeah EP, Afrane BA (2016) Managing mental illness in ghana: the state of commonly prescribed psychotropic medicines. Int J Mental Health Syst 10(1):28","journal-title":"Int J Mental Health Syst"},{"issue":"5","key":"3062_CR25","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1093\/heapol\/czx014","volume":"32","author":"I Petersen","year":"2017","unstructured":"Petersen I, Marais D, Abdulmalik J, Ahuja S, Alem A, Chisholm D et al (2017) Strengthening mental health system governance in six low-and middle-income countries in Africa and South asia: challenges, needs and potential strategies. Health Policy Plann 32(5):699\u2013709","journal-title":"Health Policy Plann"},{"issue":"1","key":"3062_CR26","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12916-024-03354-7","volume":"22","author":"C Zuo","year":"2024","unstructured":"Zuo C, Yang X, Wu X, Fan R, Liu J, Xiang H et al (2024) Medication non-adherence and self-inflicted violence behaviors among 185,800 patients with schizophrenia in the community: a 12-year cohort study. BMC Med 22(1):136","journal-title":"BMC Med"},{"issue":"1","key":"3062_CR27","doi-asserted-by":"publisher","first-page":"e016982","DOI":"10.1136\/bmjopen-2017-016982","volume":"8","author":"RL Cutler","year":"2018","unstructured":"Cutler RL, Fernandez-Llimos F, Frommer M, Benrimoj C, Garcia-Cardenas V (2018) Economic impact of medication non-adherence by disease groups: a systematic review. BMJ Open 8(1):e016982","journal-title":"BMJ Open"},{"issue":"1","key":"3062_CR28","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.psychres.2011.04.016","volume":"190","author":"J Hong","year":"2011","unstructured":"Hong J, Reed C, Novick D, Haro JM, Aguado J (2011) Clinical and economic consequences of medication non-adherence in the treatment of patients with a manic\/mixed episode of bipolar disorder: results from the European mania in bipolar longitudinal evaluation of medication (EMBLEM) study. Psychiatry Res 190(1):110\u2013114","journal-title":"Psychiatry Res"},{"issue":"6","key":"3062_CR29","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1177\/02537176241233745","volume":"46","author":"A Jayasree","year":"2024","unstructured":"Jayasree A, Shanmuganathan P, Ramamurthy P, Alwar M (2024) Types of medication non-adherence & approaches to enhance medication adherence in mental health disorders: a narrative review. Indian J Psychol Med 46(6):503\u2013510","journal-title":"Indian J Psychol Med"},{"issue":"3","key":"3062_CR30","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/jpm.12186","volume":"22","author":"E Brown","year":"2015","unstructured":"Brown E, Gray R (2015) Tackling medication non-adherence in severe mental illness: where are we going wrong? J Psychiatr Ment Health Nurs 22(3):192\u2013198","journal-title":"J Psychiatr Ment Health Nurs"},{"issue":"1","key":"3062_CR31","doi-asserted-by":"publisher","first-page":"29775","DOI":"10.1038\/s41598-025-15102-9","volume":"15","author":"GS Chanie","year":"2025","unstructured":"Chanie GS, Belachew EA, Limenh LW, Beyna AT, Mengesha AK, Bayleyegn ZW et al (2025) Prevalence and determinants of antidepressant non-adherence among patients with major depressive disorder in ethiopia: a multi-center cross sectional study. Sci Rep 15(1):29775","journal-title":"Sci Rep"},{"issue":"6","key":"3062_CR32","first-page":"1390","volume":"10","author":"P Konstantinou","year":"2020","unstructured":"Konstantinou P, Kassianos AP, Georgiou G, Panayides A, Papageorgiou A, Almas I et al (2020) Barriers, facilitators, and interventions for medication adherence across chronic conditions with the highest non-adherence rates: a scoping review with recommendations for intervention development. Translational Behav Med 10(6):1390\u20131398","journal-title":"Translational Behav Med"},{"issue":"6","key":"3062_CR33","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1111\/bcp.13215","volume":"83","author":"I Aznar-Lou","year":"2017","unstructured":"Aznar-Lou I, Fern\u00e1ndez A, Gil\u2010Girbau M, Faj\u00f3\u2010Pascual M, Moreno\u2010Peral P, Pe\u00f1arrubia\u2010Mar\u00eda MT et al (2017) Initial medication non\u2010adherence: prevalence and predictive factors in a cohort of 1.6 million primary care patients. Br J Clin Pharmacol 83(6):1328\u20131340","journal-title":"Br J Clin Pharmacol"},{"key":"3062_CR34","doi-asserted-by":"publisher","first-page":"870641","DOI":"10.3389\/fphar.2022.870641","volume":"13","author":"SD Rajahthurai","year":"2022","unstructured":"Rajahthurai SD, Farrukh MJ, Makmor-Bakry M, Tan HJ, Fatokun O, Mohd Saffian S et al (2022) Use of complementary and alternative medicine and adherence to medication therapy among stroke patients: a meta-analysis and systematic review. Front Pharmacol 13:870641","journal-title":"Front Pharmacol"},{"issue":"8","key":"3062_CR35","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1016\/j.cpr.2008.09.002","volume":"28","author":"JB Detweiler-Bedell","year":"2008","unstructured":"Detweiler-Bedell JB, Friedman MA, Leventhal H, Miller IW, Leventhal EA (2008) Integrating co-morbid depression and chronic physical disease management: identifying and resolving failures in self-regulation. Clin Psychol Rev 28(8):1426\u20131446","journal-title":"Clin Psychol Rev"},{"issue":"4","key":"3062_CR36","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/nrrheum.2011.2","volume":"7","author":"RR Edwards","year":"2011","unstructured":"Edwards RR, Cahalan C, Mensing G, Smith M, Haythornthwaite JA (2011) Pain, catastrophizing, and depression in the rheumatic diseases. Nat Rev Rheumatol 7(4):216\u2013224","journal-title":"Nat Rev Rheumatol"},{"key":"3062_CR37","unstructured":"Lebedyn Z, Zozulya K, Moroz O, Frolova A, Bandera S, Stetsko D et al (2024) Enhancing mental health services: Overcoming challenges and improving quality"},{"issue":"2","key":"3062_CR38","first-page":"1","volume":"1","author":"Q Zaman","year":"2024","unstructured":"Zaman Q (2024) Integrating mental health service in primary care: challenges and opportunities. Multidisciplinary J Healthc (MJH) 1(2):1\u201312","journal-title":"Multidisciplinary J Healthc (MJH)"},{"key":"3062_CR39","unstructured":"Daniel Ayelegne Gebeyehu HM, Bekana L, Asemamaw NT (2017) Mequanent Kassa Birarra, Wubet Worku Takele & Dessie Abebaw Angaw. Psychotropic medication non-adherence among patients with severe mental disorder attending at Bahir Dar Felege Hiwote Referral hospital, north west Ethiopia, 2017"},{"issue":"9881","key":"3062_CR40","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1016\/S0140-6736(13)60951-4","volume":"381","author":"K Morris","year":"2013","unstructured":"Morris K (2013) Revising the declaration of Helsinki. Lancet 381(9881):1889\u20131890","journal-title":"Lancet"},{"key":"3062_CR41","doi-asserted-by":"crossref","unstructured":"Owie GO, Olotu SO, James BO (2018) Reliability and validity of the medication adherence rating scale in a cohort of patients with schizophrenia from Nigeria","DOI":"10.1590\/2237-6089-2017-0077"},{"key":"3062_CR42","doi-asserted-by":"crossref","unstructured":"Misganaw Tilahun NH (2019) 2 Kenean Mekonnen, 2 Mengesha Srahbzu, 3, Ayelegne aD. Nonadherence to Antiepileptic Medications and Its Determinants among Epileptic Patients at the University of Gondar Referral Hospital, Gondar, Ethiopia, 2019","DOI":"10.1155\/2020\/8886828"},{"issue":"5","key":"3062_CR43","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1056\/NEJMra050100","volume":"353","author":"L Osterberg","year":"2005","unstructured":"Osterberg L, Blaschke T (2005) Adherence to medication. N Engl J Med 353(5):487\u2013497","journal-title":"N Engl J Med"},{"issue":"2","key":"3062_CR44","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/00002030-200201250-00017","volume":"16","author":"JC Walsh","year":"2002","unstructured":"Walsh JC, Mandalia S, Gazzard BG (2002) Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome. Aids 16(2):269\u2013277","journal-title":"Aids"},{"key":"3062_CR45","doi-asserted-by":"crossref","unstructured":"Hibdye G 1, YD, ND LB, Sintayehu aM (2013) Prevalence of Drug Non Adherence and Associated Factors among Patients with Bipolar Disorder at Outpatient Unit of Amanuel Hospital, Addis Ababa, Ethiopia, 2013","DOI":"10.4172\/2378-5756.1000003"},{"issue":"1\u20132","key":"3062_CR46","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3109\/10826080902864712","volume":"45","author":"JB Luoma","year":"2010","unstructured":"Luoma JB, O\u2019Hair AK, Kohlenberg BS, Hayes SC, Fletcher L (2010) The development and psychometric properties of a new measure of perceived stigma toward substance users. Subst Use Misuse 45(1\u20132):47\u201357","journal-title":"Subst Use Misuse"},{"issue":"3","key":"3062_CR47","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1080\/13548500600595160","volume":"11","author":"WH Van Brakel","year":"2006","unstructured":"Van Brakel WH (2006) Measuring health-related stigma\u2014a literature review. Psychol Health Med 11(3):307\u2013334","journal-title":"Psychol Health Med"},{"issue":"3","key":"3062_CR48","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1192\/bjp.bp.106.024638","volume":"190","author":"M King","year":"2007","unstructured":"King M, Dinos S, Shaw J, Watson R, Stevens S, Passetti F et al (2007) The stigma scale: development of a standardised measure of the stigma of mental illness. Br J Psychiatry 190(3):248\u2013254","journal-title":"Br J Psychiatry"},{"issue":"3","key":"3062_CR49","first-page":"227","volume":"23","author":"K Tesfay","year":"2013","unstructured":"Tesfay K, Girma E, Negash A, Tesfaye M, Dehning S (2013) Medication non-adherence among adult psychiatric out-patients in Jimma university specialized hospital, Southwest Ethiopia. Ethiop J Health Sci 23(3):227\u2013236","journal-title":"Ethiop J Health Sci"},{"issue":"1","key":"3062_CR50","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13643-020-1274-3","volume":"9","author":"A Semahegn","year":"2020","unstructured":"Semahegn A, Torpey K, Manu A, Assefa N, Tesfaye G, Ankomah A (2020) Psychotropic medication non-adherence and its associated factors among patients with major psychiatric disorders: a systematic review and meta-analysis. Syst Reviews 9(1):17","journal-title":"Syst Reviews"},{"key":"3062_CR51","unstructured":"Semahegn1 MNaA (2015) Psychotropic Drug Non Adherence and Associated Factors Among Adult Patients with Major Psychiatric Disorders Attending at Psychiatry Clinics of Hiwot Fana Specialized University Hospital and Dire Dawa Dill Chora Hospital, Eastern Ethiopia"},{"issue":"4","key":"3062_CR52","doi-asserted-by":"publisher","first-page":"288","DOI":"10.4314\/mmj.v36i4.8","volume":"36","author":"P Erohubie","year":"2024","unstructured":"Erohubie P, Oriji S, Olotu S, Agbonile I, Anozie I, Erohubie O et al (2024) Antipsychotic medication non-adherence and its determinants among out-patients with schizophrenia. Malawi Med J 36(4):288\u2013297","journal-title":"Malawi Med J"},{"key":"3062_CR53","unstructured":"Seena MC (2020) RG, PK, RKR. Noncompliance to Treatment among Persons with Mental Illness"},{"issue":"1","key":"3062_CR54","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00127-009-0041-5","volume":"45","author":"AG Bulloch","year":"2010","unstructured":"Bulloch AG, Patten SB (2010) Non-adherence with psychotropic medications in the general population. Soc Psychiatry Psychiatr Epidemiol 45(1):47\u201356","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"3062_CR55","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.psychres.2017.10.034","volume":"259","author":"IA Kretchy","year":"2018","unstructured":"Kretchy IA, Osafo J, Agyemang SA, Appiah B, Nonvignon J (2018) Psychological burden and caregiver-reported non-adherence to psychotropic medications among patients with schizophrenia. Psychiatry Res 259:289\u2013294","journal-title":"Psychiatry Res"},{"key":"3062_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejim.2023.07.008","volume":"119","author":"M Burnier","year":"2024","unstructured":"Burnier M (2024) The role of adherence in patients with chronic diseases. Eur J Intern Med 119:1\u20135","journal-title":"Eur J Intern Med"},{"key":"3062_CR57","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.schres.2020.11.002","volume":"224","author":"RS Patel","year":"2020","unstructured":"Patel RS, Sreeram V, Vadukapuram R, Baweja R (2020) Do cannabis use disorders increase medication non-compliance in schizophrenia? United States nationwide inpatient cross-sectional study. Schizophr Res 224:40\u201344","journal-title":"Schizophr Res"},{"issue":"9","key":"3062_CR58","doi-asserted-by":"publisher","first-page":"e044987","DOI":"10.1136\/bmjopen-2020-044987","volume":"11","author":"L Foley","year":"2021","unstructured":"Foley L, Larkin J, Lombard-Vance R, Murphy AW, Hynes L, Galvin E et al (2021) Prevalence and predictors of medication non-adherence among people living with multimorbidity: a systematic review and meta-analysis. BMJ Open 11(9):e044987","journal-title":"BMJ Open"},{"issue":"1","key":"3062_CR59","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1080\/02791072.1999.10471727","volume":"31","author":"W Sowers","year":"1999","unstructured":"Sowers W, Golden S (1999) Psychotropic medication management in persons with co-occurring psychiatric and substance use disorders. J Psychoactive Drugs 31(1):59\u201370","journal-title":"J Psychoactive Drugs"},{"issue":"15","key":"3062_CR60","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.4254\/wjh.v7.i15.1921","volume":"7","author":"P Hauser","year":"2015","unstructured":"Hauser P, Kern S (2015) Psychiatric and substance use disorders co-morbidities and hepatitis C: diagnostic and treatment implications. World J Hepatol 7(15):1921","journal-title":"World J Hepatol"},{"issue":"5","key":"3062_CR61","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.addbeh.2010.12.001","volume":"36","author":"CH Brown","year":"2011","unstructured":"Brown CH, Bennett ME, Li L, Bellack AS (2011) Predictors of initiation and engagement in substance abuse treatment among individuals with co-occurring serious mental illness and substance use disorders. Addict Behav 36(5):439\u2013447","journal-title":"Addict Behav"},{"key":"3062_CR62","unstructured":"Fasil, BayafersTamene1\u2217EAM (2024) Tirsit Ketsela Zeleke1, Ashenafi Kibret Sendekie3, Eyayaw Ashete Belachew3 & Samuel AgegnewWondm1. Medication non-adherence and its predictors among patients with bipolar disorder in Northwest Ethiopia"},{"key":"3062_CR63","doi-asserted-by":"crossref","unstructured":"Adane A, Zerihun D, Warkaw A, Misganaw S, Mulualem S (2024) Medication Non-adherence and associated factors among patients with mental illness at St. Amanuel Specialized Psychiatric Hospital, Addis Ababa, Ethiopia","DOI":"10.21203\/rs.3.rs-3909394\/v1"},{"issue":"9","key":"3062_CR64","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s40263-016-0368-x","volume":"30","author":"JB Levin","year":"2016","unstructured":"Levin JB, Krivenko A, Howland M, Schlachet R, Sajatovic M (2016) Medication adherence in patients with bipolar disorder: a comprehensive review. CNS Drugs 30(9):819\u2013835","journal-title":"CNS Drugs"},{"issue":"1","key":"3062_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/hup.1081","volume":"25","author":"L Berk","year":"2010","unstructured":"Berk L, Hallam KT, Colom F, Vieta E, Hasty M, Macneil C et al (2010) Enhancing medication adherence in patients with bipolar disorder. Hum Psychopharmacology: Clin Experimental 25(1):1\u201316","journal-title":"Hum Psychopharmacology: Clin Experimental"},{"key":"3062_CR66","unstructured":"Andualem T (ed) (2009) Trend analysis of males\u2019 and females\u2019 education in different school levels and school types in Addis Ababa. Proceedings of the 16th International Conference of Ethiopian Studies"},{"issue":"2","key":"3062_CR67","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1080\/09744053.2018.1485254","volume":"10","author":"K Kassie","year":"2018","unstructured":"Kassie K (2018) Gender difference in higher education in ethiopia: A case of addis Ababa university (AAU). Afr Rev 10(2):157\u2013172","journal-title":"Afr Rev"},{"key":"3062_CR68","doi-asserted-by":"crossref","unstructured":"Zhu X, Wen M, He Y, Feng J, Xu X, Liu J (2023) The relationship between level of education, cognitive function and medication adherence in patients with schizophrenia. Neuropsychiatr Dis Treat. :2439\u20132450","DOI":"10.2147\/NDT.S424694"},{"key":"3062_CR69","doi-asserted-by":"crossref","unstructured":"Agumasie Semahegn1, Torpey K 1, GTa AMNA (2020) Ankomah3 A. Psychotropic medication non-adherence and its associated factors among patients with major psychiatric disorders: a systematic review and meta-analysis","DOI":"10.1186\/s13643-020-1274-3"},{"key":"3062_CR70","unstructured":"MYABA J (2017) The Prevalence and Predictors of Antipsychotic Medication Non-adherence among Clients with Psychotic Disorders in Mzimba, Malawi May"},{"issue":"3","key":"3062_CR71","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/j.1465-3362.2010.00283.x","volume":"30","author":"B Larance","year":"2011","unstructured":"Larance B, Degenhardt L, Lintzeris N, Winstock A, Mattick R (2011) Definitions related to the use of pharmaceutical opioids: extramedical use, diversion, non-adherence and aberrant medication\u2010related behaviours. Drug Alcohol Rev 30(3):236\u2013245","journal-title":"Drug Alcohol Rev"},{"issue":"4","key":"3062_CR72","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1177\/2045125312474019","volume":"3","author":"K Higashi","year":"2013","unstructured":"Higashi K, Medic G, Littlewood KJ, Diez T, Granstr\u00f6m O, De Hert M (2013) Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review. Therapeutic Adv Psychopharmacol 3(4):200\u2013218","journal-title":"Therapeutic Adv Psychopharmacol"},{"issue":"2","key":"3062_CR73","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000497334","volume":"88","author":"RJ Baldessarini","year":"2019","unstructured":"Baldessarini RJ, Tondo L (2019) Effects of treatment discontinuation in clinical psychopharmacology. Psychother Psychosom 88(2):65\u201370","journal-title":"Psychother Psychosom"},{"key":"3062_CR74","doi-asserted-by":"publisher","first-page":"204512532097032","DOI":"10.1177\/2045125320970325","volume":"10","author":"GA Fava","year":"2020","unstructured":"Fava GA (2020) May antidepressant drugs worsen the conditions they are supposed to treat? The clinical foundations of the oppositional model of tolerance. Therapeutic Adv Psychopharmacol 10:2045125320970325","journal-title":"Therapeutic Adv Psychopharmacol"},{"key":"3062_CR75","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1016\/j.jad.2011.03.047","volume":"132","author":"R Morehouse","year":"2011","unstructured":"Morehouse R, MacQueen G, Kennedy SH (2011) Barriers to achieving treatment goals: a focus on sleep disturbance and sexual dysfunction. J Affect Disord 132:S14\u2013S20","journal-title":"J Affect Disord"},{"issue":"1","key":"3062_CR76","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/wps.20509","volume":"17","author":"AL Montejo","year":"2018","unstructured":"Montejo AL, Montejo L, Baldwin DS (2018) The impact of severe mental disorders and psychotropic medications on sexual health and its implications for clinical management. World Psychiatry 17(1):3\u201311","journal-title":"World Psychiatry"},{"key":"3062_CR77","doi-asserted-by":"crossref","unstructured":"Tareke M, Tesfaye S, Amare D, Belete T, Abate A (2018) Antipsychotic medication non-adherence among schizophrenia patients in central Ethiopia. Mar 22","DOI":"10.4102\/sajpsychiatry.v24i0.1124"},{"key":"3062_CR78","doi-asserted-by":"crossref","unstructured":"Fethia Mohammed1* BG (2024) TAY, Dessie4 aY. Antipsychotic medication non-adherence and factors associated among patients with schizophrenia in eastern Ethiopia","DOI":"10.1186\/s12888-024-05554-0"},{"key":"3062_CR79","doi-asserted-by":"crossref","unstructured":"Ramamurthy PJ, Arya S, Rudravaram VV2, Menon (2023) Vikas3; Thilakan, Pradeep. Medication nonadherence and its associated factors in psychiatric patients in India: A systematic review and meta-analysis. May","DOI":"10.4103\/indianjpsychiatry.indianjpsychiatry_249_22"},{"issue":"1","key":"3062_CR80","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12955-020-01340-0","volume":"18","author":"D Desalegn","year":"2020","unstructured":"Desalegn D, Girma S, Abdeta T (2020) Quality of life and its association with current substance use, medication non-adherence and clinical factors of people with schizophrenia in Southwest ethiopia: a hospital-based cross-sectional study. Health Qual Life Outcomes 18(1):82","journal-title":"Health Qual Life Outcomes"},{"issue":"2\u20133","key":"3062_CR81","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.schres.2009.04.018","volume":"113","author":"R Miller","year":"2009","unstructured":"Miller R, Ream G, McCormack J, Gunduz-Bruce H, Sevy S, Robinson D (2009) A prospective study of cannabis use as a risk factor for non-adherence and treatment dropout in first-episode schizophrenia. Schizophr Res 113(2\u20133):138\u2013144","journal-title":"Schizophr Res"},{"issue":"6","key":"3062_CR82","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1097\/01.nmd.0000221289.54911.63","volume":"194","author":"J Wilk","year":"2006","unstructured":"Wilk J, Marcus SC, West J, Countis L, Hall R, Regier DA et al (2006) Substance abuse and the management of medication nonadherence in schizophrenia. J Nerv Ment Dis 194(6):454\u2013457","journal-title":"J Nerv Ment Dis"},{"issue":"1","key":"3062_CR83","first-page":"97","volume":"27","author":"PW Vik","year":"2004","unstructured":"Vik PW, Cellucci T, Jarchow A, Hedt J (2004) Cognitive impairment in substance abuse. Psychiatric Clin 27(1):97\u2013109","journal-title":"Psychiatric Clin"},{"issue":"1","key":"3062_CR84","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1017\/S1092852918001426","volume":"24","author":"T Ramey","year":"2019","unstructured":"Ramey T, Regier PS (2019) Cognitive impairment in substance use disorders. CNS Spectr 24(1):102\u2013113","journal-title":"CNS Spectr"},{"issue":"2","key":"3062_CR85","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.pbb.2011.04.017","volume":"99","author":"KT Brady","year":"2011","unstructured":"Brady KT, Gray KM, Tolliver BK (2011) Cognitive enhancers in the treatment of substance use disorders: clinical evidence. Pharmacol Biochem Behav 99(2):285\u2013294","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"3062_CR86","doi-asserted-by":"publisher","first-page":"93","DOI":"10.70411\/MJHAS.2.1.2025181","volume":"2","author":"TMA Husiny","year":"2025","unstructured":"Husiny TMA (2025) A scoping review of factors contributing to relapse in substance use disorders. Mod J Health Appl Sci 2(1):93\u2013113","journal-title":"Mod J Health Appl Sci"},{"issue":"6","key":"3062_CR87","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.38124\/ijisrt\/25jun902","volume":"10","author":"O Ibiyemi","year":"2025","unstructured":"Ibiyemi O, Idris A, Oluwakemi A, Praise O, Omotayo F, Ayodeji O et al (2025) Psychosocial factors as predictors of relapse rate among substance use disorders patients in A mental health facility in Nigeria. Int J Innovative Sci Res Technol 10(6):1454\u20131462","journal-title":"Int J Innovative Sci Res Technol"},{"issue":"2","key":"3062_CR88","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/wps.21073","volume":"22","author":"ND Volkow","year":"2023","unstructured":"Volkow ND, Blanco C (2023) Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention. World Psychiatry 22(2):203\u2013229","journal-title":"World Psychiatry"},{"key":"3062_CR89","doi-asserted-by":"crossref","unstructured":"Hibdye G 1, YD, ND LB (2013) Sintayehu5* aM. Prevalence of Drug Non Adherence and Associated Factors among Patients with Bipolar Disorder at Outpatient Unit of Amanuel Hospital, Addis Ababa, Ethiopia, 2013","DOI":"10.4172\/2378-5756.1000003"},{"key":"3062_CR90","doi-asserted-by":"crossref","unstructured":"Abiodun O, Adewuya MBCB, FWACP FMCPa, Olugbenga A, Owoeye MBCB, Adebayo FMCP, Erinfolami M.B.B.S. R (2009) F.M.C.Psych. c, Ayodele O. Coker M.D., F.W.A.C.P. a, Oluyemi C. Ogun M.B.B.S., F.W.A.C.P. b, Adeniran O. Okewole M.B.B.S. b, Mobolaji U. Dada M.B.B.S. b, Christian N. Eze M.B.B.S. b, Mashudat A. Bello-Mojeed M.B.B.S. b, Taiwo O. Akindipe M.B.B.S. c, Andrew T. Olagunju M.B.B.S. c,. Prevalence and correlates of poor medication adherence amongst psychiatric outpatients in southwestern Nigeria. March\u2013April","DOI":"10.1016\/j.genhosppsych.2008.12.005"},{"key":"3062_CR91","unstructured":"Fatema K Attitude towards Psychiatric Medication among the Providers and Recipients of Mental Health Services 2020"},{"key":"3062_CR92","unstructured":"Ben Avraham L (2020) Understanding medication adherence among individuals with severe mental illness: relationship to treatment approaches. University of Pennsylvania"},{"key":"3062_CR93","volume-title":"Exploring the impact of internalized negative stereotypes on black women\u2019s identity development","author":"AN Clarke","year":"2025","unstructured":"Clarke AN (2025) Exploring the impact of internalized negative stereotypes on black women\u2019s identity development. Walden University, Mental Health, and Resilience"},{"issue":"12","key":"3062_CR94","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1176\/appi.ps.52.12.1615","volume":"52","author":"JA Sirey","year":"2001","unstructured":"Sirey JA, Bruce ML, Alexopoulos GS, Perlick DA, Friedman SJ, Meyers BS (2001) Stigma as a barrier to recovery: perceived stigma and patient-rated severity of illness as predictors of antidepressant drug adherence. Psychiatric Serv 52(12):1615\u20131620","journal-title":"Psychiatric Serv"},{"key":"3062_CR95","doi-asserted-by":"crossref","unstructured":"Kansra S, Calvert R, Jones S (2021) Stigma from medication use: an under recognised burden of care. Breathe. ;17(1)","DOI":"10.1183\/20734735.0002-2021"},{"issue":"1","key":"3062_CR96","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1093\/clipsy.7.1.48","volume":"7","author":"PW Corrigan","year":"2000","unstructured":"Corrigan PW (2000) Mental health stigma as social attribution: implications for research methods and attitude change. Clin Psychol Sci Pract 7(1):48","journal-title":"Clin Psychol Sci Pract"},{"issue":"11","key":"3062_CR97","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1002\/da.20413","volume":"26","author":"CF Yen","year":"2009","unstructured":"Yen CF, Chen CC, Lee Y, Tang TC, Ko CH, Yen JY (2009) Association between quality of life and self-stigma, insight, and adverse effects of medication in patients with depressive disorders. Depress Anxiety 26(11):1033\u20131039","journal-title":"Depress Anxiety"},{"issue":"1","key":"3062_CR98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40271-012-0001-0","volume":"6","author":"J Schabert","year":"2013","unstructured":"Schabert J, Browne JL, Mosely K, Speight J (2013) Social stigma in diabetes: a framework to understand a growing problem for an increasing epidemic. Patient-Patient-Centered Outcomes Res 6(1):1\u201310","journal-title":"Patient-Patient-Centered Outcomes Res"},{"key":"3062_CR99","unstructured":"b CIF-La DPA et al (2019), d DF-L,. Medication adherence and barriers among low-income, uninsured patients with multiple chronic conditions"},{"key":"3062_CR100","unstructured":"Shaya SKF (2008) Medication Non-adherence is Associated with Increased Medical Health Care Costs"},{"issue":"6","key":"3062_CR101","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.sapharm.2018.09.006","volume":"15","author":"CI Fernandez-Lazaro","year":"2019","unstructured":"Fernandez-Lazaro CI, Adams DP, Fernandez-Lazaro D, Garcia-Gonz\u00e1lez JM, Caballero-Garcia A, Miron-Canelo JA (2019) Medication adherence and barriers among low-income, uninsured patients with multiple chronic conditions. Res Social Administrative Pharm 15(6):744\u2013753","journal-title":"Res Social Administrative Pharm"},{"issue":"1","key":"3062_CR102","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3390\/medicina61010153","volume":"61","author":"U Religioni","year":"2025","unstructured":"Religioni U, Barrios-Rodr\u00edguez R, Requena P, Borowska M, Ostrowski J (2025) Enhancing therapy adherence: impact on clinical outcomes, healthcare costs, and patient quality of life. Medicina 61(1):153","journal-title":"Medicina"},{"key":"3062_CR103","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.socscimed.2017.10.007","volume":"194","author":"LJ Goldsmith","year":"2017","unstructured":"Goldsmith LJ, Kolhatkar A, Popowich D, Holbrook AM, Morgan SG, Law MR (2017) Understanding the patient experience of cost-related non-adherence to prescription medications through typology development and application. Soc Sci Med 194:51\u201359","journal-title":"Soc Sci Med"},{"issue":"3","key":"3062_CR104","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1017\/bpp.2019.1","volume":"5","author":"JM Jachimowicz","year":"2021","unstructured":"Jachimowicz JM, Gladstone JJ, Berry D, Kirkdale CL, Thornley T, Galinsky AD (2021) Making medications stick: improving medication adherence by highlighting the personal health costs of non-compliance. Behav Public Policy 5(3):396\u2013416","journal-title":"Behav Public Policy"},{"issue":"8","key":"3062_CR105","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1080\/13696998.2016.1176031","volume":"19","author":"JX Zhang","year":"2016","unstructured":"Zhang JX, Meltzer DO (2016) Identifying patients with cost-related medication non-adherence: a big-data approach. J Med Econ 19(8):806\u2013811","journal-title":"J Med Econ"},{"issue":"1","key":"3062_CR106","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1186\/s12888-016-1156-3","volume":"16","author":"S Joe","year":"2016","unstructured":"Joe S, Lee JS (2016) Association between non-compliance with psychiatric treatment and non-psychiatric service utilization and costs in patients with schizophrenia and related disorders. BMC Psychiatry 16(1):444","journal-title":"BMC Psychiatry"},{"issue":"1","key":"3062_CR107","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1002\/j.2051-5545.2011.tb00014.x","volume":"10","author":"M De Hert","year":"2011","unstructured":"De Hert M, Correll CU, Bobes J, Cetkovich-Bakmas M, Cohen D, Asai I et al (2011) Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry 10(1):52","journal-title":"World Psychiatry"},{"issue":"1","key":"3062_CR108","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13033-020-00410-6","volume":"14","author":"C Ee","year":"2020","unstructured":"Ee C, Lake J, Firth J, Hargraves F, De Manincor M, Meade T et al (2020) An integrative collaborative care model for people with mental illness and physical comorbidities. Int J Mental Health Syst 14(1):83","journal-title":"Int J Mental Health Syst"},{"issue":"17","key":"3062_CR109","doi-asserted-by":"publisher","first-page":"6034","DOI":"10.3390\/jcm14176034","volume":"14","author":"S Patel","year":"2025","unstructured":"Patel S, Huang M, Miliara S (2025) Understanding treatment adherence in chronic diseases: challenges, consequences, and strategies for improvement. J Clin Med 14(17):6034","journal-title":"J Clin Med"},{"issue":"7","key":"3062_CR110","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.3390\/pharmaceutics13071100","volume":"13","author":"K Kvarnstr\u00f6m","year":"2021","unstructured":"Kvarnstr\u00f6m K, Westerholm A, Airaksinen M, Liira H (2021) Factors contributing to medication adherence in patients with a chronic condition: a scoping review of qualitative research. Pharmaceutics 13(7):1100","journal-title":"Pharmaceutics"},{"key":"3062_CR111","doi-asserted-by":"crossref","unstructured":"Goldberg JF, Ernst CL (2018) Managing the side effects of psychotropic medications. American Psychiatric Pub","DOI":"10.1176\/appi.books.9781615378517"},{"issue":"2","key":"3062_CR112","doi-asserted-by":"publisher","first-page":"117","DOI":"10.30574\/ijsra.2024.12.2.1219","volume":"12","author":"EC Jiakponna","year":"2024","unstructured":"Jiakponna EC, Agbomola JO, Ipede O, Karakitie L, Ogunsina A, Adebayo K et al (2024) Psychosocial factors in chronic disease management: implications for health psychology. Int J Sci Res Arch 12(2):117\u2013128","journal-title":"Int J Sci Res Arch"},{"issue":"11","key":"3062_CR113","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1001\/archpsyc.61.11.1097","volume":"61","author":"T Vos","year":"2004","unstructured":"Vos T, Haby MM, Barendregt JJ, Kruijshaar M, Corry J, Andrews G (2004) The burden of major depression avoidable by longer-term treatment strategies. Arch Gen Psychiatry 61(11):1097\u20131103","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"3062_CR114","doi-asserted-by":"publisher","first-page":"e010035","DOI":"10.1136\/bmjopen-2015-010035","volume":"6","author":"MA Mohammed","year":"2016","unstructured":"Mohammed MA, Moles RJ, Chen TF (2016) Medication-related burden and patients\u2019 lived experience with medicine: a systematic review and metasynthesis of qualitative studies. BMJ Open 6(2):e010035","journal-title":"BMJ Open"}],"container-title":["Social Psychiatry and Psychiatric Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00127-026-03062-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00127-026-03062-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00127-026-03062-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T20:04:04Z","timestamp":1785441844000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00127-026-03062-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,24]]},"references-count":114,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["3062"],"URL":"https:\/\/doi.org\/10.1007\/s00127-026-03062-y","relation":{},"ISSN":["0933-7954","1433-9285"],"issn-type":[{"value":"0933-7954","type":"print"},{"value":"1433-9285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,24]]},"assertion":[{"value":"4 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical clearance was obtained from the Ethical Review Committee of the University of Gondar. Verbal informed consent was obtained from all participants after a clear explanation of their rights, including the right to withdraw from the study at any time without consequence. Confidentiality and anonymity were strictly ensured, and participation was entirely voluntary, with no financial or other incentives provided and no form of coercion applied. All data were securely safeguarded by the principal investigator. Participants who experienced significant side effects or inadequate clinical improvement were referred for appropriate evaluation and management by psychiatry clinicians.","order":3,"name":"Ethics","label":"Ethical approval and consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}